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ABSTRACT	 	Prospective	study	on	the	comparison	of	mydiriatic	effect	of	Tropicamide	0.8%	and	Phenylephrine	5%	in	teenagers	 and	 geriatric	 people	was	 carried	 out	 in	 suthrama	Eye	Hospital	madanapalle,	 India.	 The	main	objective	 of	 this	 study	was	 to	 compare	 the	mydriatic	 effect	 of	 a	 combination	 of	 drug	 in	 teenagers	 and	geriatric	people.	It	also	evaluated	the	ADR’s	produced	and	the	efficacy	of	the	drug	in	two	age	groups.	In	this	study	population	majority	of	the	subjects	were	female	in	group	A	and	male	in	group	B.	Among	the	whole	population	under	study	 in	group	A	and	B	no	one	has	reported	with	any	case	of	congenital	anomalies.	A	number	of	ADR’s	are	reported	but	no	serious	adverse	events	had	occurred.	The	study	was	carried	out	in	100	eyes	ie.	50	subjects	whom	are	divided	into	2	groups	based	on	age.	The	comparison	of	mydriatic	effect	was	done	 in	 each	 group	 after	 instilling	 one	 drop	 of	 a	 combination	 of	 0.08%	 Tropicamide	 and	 0.5%	Phenynilephrine.	The	pupillary	size	where	measured	before	and	after	administration	of	drug	and	the	results	were	 compared.	 The	 results	 showed	 that	 there	 is	 a	 large	 difference	 in	 the	 normal	 pupil	 size	 between	teenagers	and	geriatric	people.	After	dilation	the	difference	in	pupil	size	was	statistically	significant	among	the	 two	 groups.	 The	 study	 concludes	 that	 the	 pupillary	 dilation	 produced	 by	 administering	 0.8%	Tropicamide	and	5%	Phenylephrine	produces	higher	mydriatic	effect	in	teenagers	than	geriatric	people.	
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INTRODUCTION	Mydriasis	is	the	dilation	of	the	pupil,	usually	defined	as	 when	 having	 a	 non-physiological	 cause,[1]	 but	sometimes	defined	as	potentially	being	a	physiologi-cal	pupillary	response.[2]	Non-physiological	causes	of	
mydriasis	 include	 disease,	 trauma,	 or	 the	 use	 of	drugs.	Normally,	as	part	of	the	pupillary	light	reflex,	the	pupil	dilates	in	the	dark	and	constricts	in	the	light	to	respectively	improve	vividity	at	night	and	to	pro-tect	the	retina	from	sunlight	damage	during	the	day.		A	mydriatic	pupil	will	remain	excessively	large	even	in	a	bright	environment.	The	excitation	of	the	radial	fibres	of	the	iris	which	increases	the	pupillary	aper-ture	is	referred	to	as	a	mydriasis.	More	generally,	my-driasis	also	refers	to	the	natural	dilation	of	pupils,	for	instance	in	low	light	conditions	or	under	sympathetic	stimulation.	An	informal	term	for	mydriasis	is	blown	pupil,[3]	and	is	used	by	medical	providers.	It	is	usually	used	to	re-fer	to	a	fixed,	unilateral	mydriasis,	which	could	be	a	symptom	of	raised	intracranial	pressure.	The	opposite,	constriction	of	the	pupil,	is	referred	to	as	miosis.	Both	mydriasis	and	miosis	can	be	physio-logical.	Anisocoria	is	the	condition	of	one	pupil	being	more	dilated	than	the	other.	
Effects:	Natural	release	of	the	hormone	oxytocin	can	cause	 mild	 to	 moderate	 mydriasis.	 Strong	 sexual	arousal	can	often	lead	to	very	enlarged	pupils,	rather	
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than	the	minor	dilation	observed	during	sexual	affec-tion.	
Autonomic	neuropathy:	The	parasympathetic	nerv-ous	supply,	which	causes	constriction	of	the	pupil,	or	miosis,	is	supplied	by	cranial	nerve	III,	the	oculomo-tor	nerve.	Damage	to	this	nerve	typically	manifests	it-self	as	mydriasis,	because	the	sympathetic	supply	to	the	 pupil,	 which	 causes	 mydriasis,	 remains	 unaf-fected,	and	therefore	unopposed.	Multiple	 central	 nervous	 system	 disorders	 e.g.	 epi-lepsy,	 stroke,	 and	 impending	 brain	 herniation	 are	known	to	lead	to	temporal	mydriasis	as	well.	A	brain	catastrophe,	or	a	rapidly	 increasing	brain	mass,	can	cause	compression	of	the	oculomotor	nerve.	
Traumatic	pupillary	response	In	cases	of	head	injury	or	orbit	trauma	(eye	injury),	the	iris	sphincter	(the	muscle	responsible	for	closing	the	 pupil)	 or	 the	 nerves	 controlling	 it	 can	 be	 dam-aged,	reducing	or	eliminating	consensual	reactivity	to	light.	
Mydriatics	A	mydriatic	is	an	agent	that	induces	dilation	of	the	pu-pil,	 The	 commonly	 used	 mydriatics	 comprise	 two	groups	of	drugs	Parasympatholytic	and	Sympathomi-metic	drugs.	Most	mydriatics	reach	their	maximal	ef-fect	 by	 30	 to	 6o	minutes,	 although	 in	 children	 and	people	with	 deeply	 pigmented	 irises	 this	may	 take	longer.	
Parasympatholytic	drugs:	which	cause	pupillary	di-latation	and	paralysis	of	accommodation	by	render-ing	the	sphincter	pupillae	and	ciliary	muscles	insen-sitive	to	acetylcholine.	
Atropine	(0.5	to	2%):	The	most	powerful	cyclople-gic	 available,	 producing	 mydriasis	 and	 cycloplegia	lasting	up	to	2	weeks.	It	can	be	temporarily	reversed	by	I:	IOO	intracameral	acetylcholine.	Indications:	(a)	Treatment	of	anterior	uveitis.	(b)	Refracting	children	under	5	years	of	age	Systemic	side-effects:	Atropine,	hyoscine,	 and	 (rarely)	homatropine	may	cause	dry-ness	and	flushing	of	the	skin,	thirst	and	tachycardia,	especially	in	infants.	Delirium	and	confusion	may	also	occur,	 particularly	 in	 the	 elderly.	 These	 effects	 are	due	to	systemic	absorption	and	can	be	prevented	by	pressing	over	the	lacrimal	sac	or	by	tipping	the	head	
Oxyphenonium	(Antrenyl)	(1	and	5%):	Produces	a	powerful	mydriasis	lasting	up	to	4	days	and	cyclople-gia	lasting	up	to	I2	days.	Indications:	Useful	substitute	for	atropine	in	sensitive	patients.	
Hyoscine	 (Scopolamine)	 (0-25	 and	 0-5%):	 Pro-duces	a	powerful	mydriasis	and	cycloplegia	lasting	up	to	5	days.	Indications:	Treatment	of	anterior	uveitis	in	atropine-sensitive	patients.		
Homatropine	(I	to	5%):	Mydriasis	lasts	up	to	2	days.	It	 does	 not	 cause	 complete	 cycloplegia	 in	 children.	Augmented	by	cocaine	and	reversed	by	eserine.	Indi-cations:	 (a)	Ophthalmoscopy.	 (b)	Preoperatively	 for	cataract	extraction	
Eucatropine	(Euphthalmine)	(5	and	10%):	Effec-tive	mydriatic	 lasting	 only	 4	 hours,	 producing	 little	cycloplegia.	 Indications:	 (a)	 Ophthalmoscopy.	 (b)	Provocative	test	in	suspected	closed-angle	glaucoma.		
Cyclopentolate	(Mydrilate,	Cyclogyl)	(0.5	to	2%):	Short-acting	 mydriatic	 and	 cycloplegic.	 Indications:	(a)	Refraction.	Maximal	cycloplegia	occurs	within	45	minutes	and	persists	for	30	minutes.	Complete	recov-ery	occurs	within	24	hours	but	can	be	reduced	to	6	hours	by	2%	pilocarpine.	(b)	Ophthalmoscopy.	Maxi-mal	mydriasis	within	30	minutes.	Particularly	valua-ble	in	patients	with	heavily	pigmented	irides.	(c)	Pre-operatively	for	cataract	extraction.		
Tropicamide	(1	and	2%):	Rapidly-acting	mydriatic	and	 cycloplegic	 reaching	 its	maximal	 activity	 in	 20	minutes	and	lasting	6	hours.	Indications:	(a)	Refrac-tion	 in	adults.	Maximal	cycloplegia	persists	 for	only	20	minutes.	(b)	Ophthalmoscopy.	(c)	Preoperatively	for	cataract	extraction.	Ocular	side-effects	(i)	Blurring	of	vision	and	inability	to	accommodate	due	to	cyclo-plegia.	(2)	Precipitation	of	closed-angle	glaucoma	in	patients	with	narrow	angles.	(3)	Contact	dermatitis	in	5	per	 cent	of	patients	using	atropine	and	 less	 com-monly	with	hyoscine.	
Sympathomimetic	drugs:	which	imitate	or	potenti-ate	the	action	of	adrenaline	and	produce	pupillary	di-latation	 but	 no	 cycloplegia.	 These	 drugs	 potentiate	the	action	of	parasympatho-lytic	drugs	
Phenylephrine	 (Neo-synephrine)	 (10%):	 Pro-duces	 mydriasis	 without	 cycloplegia	 within	 20	minutes	and	lasts	3	hours.	Particularly	effective	when	combined	with	a	parasympatholytic	mydriatic.	Indi-cations:	(a)	Ophthalmoscopy.	(b)	Breaking	posterior	synechiae.	(c)	Preventing	iris	cysts	in	patients	using	long-acting	 anticholinesterases	 (use	 2-5%)	 (d)	 Pre-operatively	for	cataract	extraction.	
Ephedrine	 (5%):	 Produces	 mydriasis	 within	 30	minutes,	lasting	3	hours.Indication:	Ophthalmoscopy.	
Hydroxyamphetamine	 (Paredrine)	 (1%):	 Pro-duces	mydriasis	within	40	minutes.	Indication:	Oph-thalmoscopy.		
Adrenaline:	Very	poor	mydriatic	when	instilled	into	the	normal	eye,	but	a	1:1000	solution	will	dilate	the	pupil	of	a	patient	with	Horner's	syndrome.		
Indications:	(a)	Simple	glaucoma.	1	to	2%	solutions	decrease	aqueous	production	and	 improve	outflow.	(b)	 Conjunctival	 decongestion.	 (c)	 Preventing	 iris	cysts	in	patients	using	longacting	anticholinesterases	
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(i	to	2%)	(d)	Diagnosis	of	Horner's	syndrome.	(e)	De-creasing	 the	 absorption	 of	 local	 anaesthetics	 (1:	50,000	or	1	:	100,000).		
Cocaine	 (2	 to	 4%):	Produces	mydriasis	 within	 20	minutes	lasting	2	hours	together	with	a	partial	cyclo-plegia.	Augments	the	action	of	homatropine.	
Indications:	(a)	Ophthalmoscopy.	(b)	Preoperatively	for	 cataract	 extraction.	 (c)	 Local	 anesthetic.	 Ocular	side-effects	 (1)	 Precipitation	 of	 closed-angle	 glau-coma	 in	patients	with	narrow	angles.	 (2)	Transient	corneal	oedema	may	occur	with	phenylephrine.	 (3)	Melanin	deposits	in	the	conjunctiva	and	cornea	with	adrenaline.	 (4)	 Macular	 oedema	 is	 an	 uncommon	side-effect	of	adrenaline	therapy.	(5)	Ocular	pain	and	stinging.	 (6)	 Desiccation	 of	 the	 corneal	 epithelium	with	cocaine.		
Systemic	 side-effects:	 The	 adrenergic	 drugs	 may	produce	tachycardia	and	palpitations	and	should	be	used	with	caution	in	patients	with	hypertensive	car-diovascular	 disease.	 Cocaine	may	produce	 hyperre-flexia,	 restlessness,	 delirium,	 tachycardia,	 irregular	respiration,	chills	and	fever,	the	result	of	central	nerv-ous	system	stimulation	which	may	terminate	in	con-vulsions.	These	side-effects	may	be	counteracted	by	a	short-acting	barbiturate.	Compound	MYDRICAINE	is	a	 solution	 of	 atropine,	 procaine,	 and	 adrenaline,	which	when	injected	subconjunctivally	produces	my-driasis	within	a	minute.	Indication:	When	a	very	pow-erful	mydriatic	is	required.	
Mydriatic	 combinations:	Phenylephrine	 (5%)	 and	Tropicamide	(0.8%)	combination	is	commonly	used	in	ophthalmology	today.	The	major	advantage	of	this	combination	is	that	it	produces	quick	mydriasis	and	mydriatic	effect	persists	to	facilitate	ocular	examina-tion.	
Indications:	 Ophthalmoscopic	 examination,	 Slit	lamp	examination,	Retinal	photography,	Prior	to	ocu-lar	surgery	and	other	diagnostic	procedures.	It	is	also	used	
• As	an	adjunct	in	the	treatment	of	anterior	uveitis	
• In	 the	management	 of	 anterior	 segment	 burns	(to	dilate	the	pupil	and	prevent	iris	adhesions	to	the	lense)	
• In	cycloplegic	refraction	
• For	 the	management	of	 iridocyclitis	associated	with	stromal	keratitis	
• For	the	management	of	uveal	 inflammation	as-sociated	with	fungal	keratitis	
ADR:	On	topical	application	 there	may	be	 transient	burning	 or	 stinging	 sensation	 and	 lacrimation.	Blurred	 vision,	 photophobia	 and	 allergic	 reactions	may	occur.		
The	aging	eye:	The	components	of	human	eyes	usu-ally	last	a	life	time.	There	may	be	structural	as	well	as	
functional	 disturbances	 associated	 with	 aging.	 Sys-temic	diseases	such	as	diabetes	mellitus	and	hyper-tension	may	 hasten	 the	 onset	 and	 degree	 of	 ocular	problems.	 There	 are	 some	 positive	 compensations	that	help	 the	aging	of	 eye.	 For	 example,	 the	human	macula	is	particularly	vulnerable	to	damage	from	ul-tra	violet	and	blue	light.	Fortunately,	the	yellow	pig-ment	 effectively	 absorbs	 or	 scatters	 away	 most	 of	these	harmful	wavelengths,	thus	diminishing	the	po-tential	damage	to	macula.	One	of	the	more	remarka-ble	aspects	of	the	aging	eye	is	that	the	eye	lense	con-tinually	acquires	new	layers	of	fibres,	becoming	both	progressively	 thicker	 and	 steeper.	 These	 changes	would	normally	lead	to	an	increase	in	lense	focusing	power	 and	 tendency	 toward	 near	 sightedness	 in	older	 eyes.	 Although	 the	 population	 aged	 above	 50	years	 is	known	to	be	about	12-15%	in	our	country,	we	have	no	data	so	far	that	defines	the	actual	causes	of	ocular	problems	 in	 elderly,	 except	 for	major	dis-eases	like	cataract	and	glaucoma.	
METHODOLOGY	
Place	of	Study:	The	study	was	conducted	at	the	Mal-abar	 Eye	Hospital,	 Eranjippalam,	 Calicut,	 Kerala	 In-dia.	The	study	has	got	institutional	ethics	committee	approval	designed	to	carried	out	for	period	of	three	months.	On	the	population	of	50	subjects	by	following	interventional	study	design.	
Subjects	and	Recruitment:	Patients	are	enrolled	in	the	 study	 based	 on	 inclusion	 and	 exclusion	 criteria	and	written	consent	was	obtained	 from	all	 the	sub-jects.		
	Inclusion	Criteria:	a.	Both	Male	and	Female,	b.	Age	for	group	A	is	between	16-20	and	for	Group	B	is	be-tween	 60-75.	 c.	 Those	 who	 are	 willing	 to	 give	 in-formed	consent.	
Exclusion	Criteria:	Patients	with	a	history	of	cardiac	diseases,	High	Blood	pressure,	History	of	past	Ocular	surgery,	 Glaucoma,	 Eye	 trauma,	 Diabetes,	 Allergic	patients,	Patients	with	infection	and	inflammation	of	eye,	Patients	with	more	 than	 .25	mm	 of	 anisocoria	before	dilation.	
Study	 Protocol:	 100	 eyes	 in	 50	 patients	 requiring	pupillary	dilation	as	part	of	their	visit	to	Malabar	Eye	Hospital	Eranhippalam	between	November	2015	 to	January	2016	were	recruited	to	the	study.		The	subjects	were	divided	into	two	groups.		
Group	A:	includes	subjects	in	an	age	group	between	18	to	20	years	and		
Group	B:	include	subjects	with	age	between	60	to	75		The	pupil	diameter	of	both	the	eyes	were	measured	with	a	transparent	measuring	scale	in	all	the	subjects	in	both	the	groups.	After	measuring	the	normal	pupil	size	 one	 drop	 of	 Tropicamide	 plus	 (Tropicamide	
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0.8%	 and	 Phenylephrine	 5%)	 was	 administered	 to	both	eyes	of	all	subjects.	The	eye	drops	were	placed	between	the	conjunctival	sac	of	the	lower	eye	lid	and	patients	 were	 directed	 to	 close	 their	 eyes	 approxi-mately	one	minute	after	drop	delivery	to	prevent	loss	of	medication	 through	 punctum	 in	 the	 conjunctival	sac.		Diameter	of	pupil	of	all	subjects	were	measured	after	15	minutes,	30	minutes	and	45	minutes	after	drug	ad-ministration.	 The	 adverse	 effects	 produced	 and	 re-turn	 of	 ocular	 function	 was	 assessed	 by	 interview	method.		
RESULTS	AND	DISCUSSION		The	pupil	 is	a	aperture	present	 in	 the	centre	of	 the	iris.	It	limits	the	amount	of	light	reaching	the	retina.	The	pupil	is	under	the	control	of	autonomic	nervous	system.	Parasympatholytics	as	well	as	Sympathomi-metic	drugs	have	been	used	to	dilate	the	pupil.	The	parasympathetic	regulation	dominates	over	the	sym-pathetic	effect	 in	 the	control	of	 the	pupil.	But	Para-sympatholytics	alone	may	not	provide	sufficient	pu-pil	dilation.	Combination	of	both	drugs	offers	greater	pupil	dilation.		In	the	hospital	where	the	study	was	conducted,	Trop-icamide	plus	(Tropicamide	0.8%	and	Phenylephrine	5%)	eye	drops	was	frequently	used	for	the	purpose	of	pupil	dilation	and	for	cycloplegic	refraction	for	 fun-dus	examination	and	photocoagulation	and	 for	pre-venting	 the	 formation	of	posterior	 iris	 synechiae	 in	uveitis.	 Dilation	 is	 also	 essential	 in	 preparation	 for	several	 intra	ocular	procedures	such	as	cataract	ex-traction.	This	study	was	undertaken	to	compare	the	difference	in	pupillary	response	to	a	same	drug	in	teenagers	and	geriatric	people.	The	patients	who	have	satisfied	the	inclusion	 criteria	where	 enrolled	 for	 the	 study	 and	are	 assigned	 in	 two	 groups.	 Such	 as	 Group	 A	 and	Group	B.	A	total	of	50	patients	where	included	(ie.	100	eyes)	in	the	study.		
Age:	In	Group	A	majority	of	the	subjects	(56%)	were	of	19	years	old.	36%	of	the	subjects	belonged	to	the	age	18	and	remaining	8	percent	of	the	subjects	are	of	17	years	old	(Table	1).	
Table 1: Age distribution of subjects in group A 
Age	(Years)	 Frequency	 Percentage	
17	 2	 8	
18	 9	 36	
19	 14	 56	
TOTAL	 25	 100	
 
Figure 1: Distribution of subjects based on age in 
group A	In	the	study	population	of	Group	A,	majority	of	sub-jects	fell	under	the	age	of	19	(56%).	36%	of	the	sub-jects	belonged	to	the	age	of	18	&remaining	8%of	the	subjects	are	of	17	years	old.	In	Group	B	majority	of	the	subjects	fell	under	the	age	group	of	60	to	65	years	(40%).	36%	of	the	subjects	belonged	 to	 the	 age	 group	 65-70	 years	 and	 the	 re-maining	24%	of	subjects	were	in	the	age	group	of	70	to	75	years	(Table	2).	
Table 2: Age distribution of subjects in group B 
Age (Years) Frequency Percentage 
60-65 10 40 
65-70 9 36 
70-75 6 24 
TOTAL 25 100 
 
Figure 2: Distribution of subjects based on age in 
group B	In	 this	study	population	of	group	B,	majority	of	 the	subjects	 fell	 under	 the	 age	 group	of	 60	 to	65	 years	(40%),	36%	of	the	subjects	belonged	to	the	age	group	65	–	70	and	the	remaining	24%	of	the	subjects	were	in	the	age	group	of	70	–	75	years	Generally,	pupils	are	relatively	small	at	birth,	 larger	during	adolescence	and	tends	to	slowly	grow	smaller	with	increasing	age.		
Gender:	In	group	A	out	of	the	total	subject’s	28	per-cent	were	male	and	72	percent	were	female	(Table	3)	whereas	 majority	 of	 the	 subjects	 in	 Group	 B	 were	male	(56%)	and	44%	were	female	(Table	4)	
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Table 3: Distribution of subjects based on gender in 
group A and B 
Gender Group A Group B Frequency	 %	 Frequency	 %	
Male	 7	 28	 14	 56	
Female	 18	 72	 11	 44	
Total	 25	 100	 25	 100	
 
Figure 3: Distribution of subjects based on gender in 
group A and B	The	Study	group	A	consisted	of	7	males	(28%)	and	18	females	 (72%)	 and	 B	 consisted	 of	 14	males	 (56%)	and	11	females	(44%).	The	study	shows	that	there	is	no	 significant	 difference	 in	 pupillary	 size	 between	male	and	female.		
Table 4: Distribution of subjects based Congenital 
Anomalies 
Group Congenital Anomalies Frequency Percentage 
Group A No 25 100 
Group B No 25 100 Among	the	whole	population	under	study	in	group	A	and	B	no	one	has	reported	with	any	case	of	congenital	anomalies.	
ADR:	As	per	the	study	the	adverse	effects	produced	by	Tropicamde	and	Phenylephrine	varies	depending	upon	the	subjects.	(Table	5).	In	both	groups	A	and	B,	blurring	of	vision	was	pro-duced	as	a	major	side	effect	in	all	the	subjects	(100%).	Transient	pain	after	the	administration	of	drug	was	reported	 in	40%	of	subjects	of	group	A	and	20%	of	subjects	in	group	B.	Photophobia	was	reported	in	all	the	subjects	of	group	A	and	group	B	(100%)	during	the	period	of	dilation.	Itching	was	uncommon,	which	was	reported	in	only	4%	subjects	of	group	A	and	8%	of	subjects	in	group	B.	Headache	was	reported	in	32%of	subjects	in	group	A	but	 only	 12%	 subjects	were	 reported	 having	 head-ache	in	group	B.	
Table 5: Distribution of subjects based on ADR 
ADR	 Group	A	 Group	B	Fre-
quency	 Per-cent-age	 Fre-quency	 Per-cent-age	
Blurring 
of vision	 25	 100	 25	 100	
Pain	 10	 40	 5	 20	
Photopho-
bia	 25	 100	 25	 100	
Itching	 1	 4	 2	 8	
Headache	 8	 32	 3	 12	
Lacrima-
tion	 5	 20	 7	 28	
 
Figure 4: Distribution of subjects based on ADR	During	the	study	period,	after	administration	of	the	mydriatic	 drug	 various	 adverse	 reactions	 were	 re-ported.	Such	as	blurring	of	vision,	pain,	photophobia,	itching,	headache	and	lacrimation.	Lacrimation	 was	 shown	 by	 22%	 of	 the	 subjects	 of	group	A	and	28%	of	subjects	in	group	B.		
Pupil	size		
Before	Administration	of	Drug:	The	normal	pupil	size	in	adults	varies	from	2mm	to	4	mm	in	diameter	in	bright	light.	As	per	the	study	the	mean	of	normal	pupil	size	of	group	A	was	found	to	be	3.52	mm	and	of	group	B	it	was	2.84	mm	(Table	6	&	7).	This	shows	that	the	group	A	in	which	the	subjects	are	teenagers	have	larger	pupil	size	than	geriatric	people	in	group	B.	As	we	age	the	muscles	that	control	our	pupil	size	and	re-action	to	light	loss	some	strength	this	causes	pupil	to	become	 smaller	 and	 less	 responsible	 to	 changes	 in	ambient	lighting.		
After	Administration	of	Drug	 (Table	 8):	After	 ad-ministering	one	drop	of	the	drug	(Tropicamide	0.8%	and	Phenylephrine	5%)	The	pupil	size	was	measured	at	15	minutes,	30	minutes	and	45	minutes	in	both	the	groups.	There	was	a	gradual	increase	in	pupil	diame-ter	in	both	groups	but	the	pupil	response	was	more	rapid	 and	of	 grater	magnitude	 in	 group	A.	After	15	minutes	the	mean	pupil	diameter	was	found	larger	in	group	A	ie.	6.2	mm	and	5.28	mm	in	group	B.	The	ob-served	 difference	 was	 statistically	 significant	(p<0.05).	The	mean	pupil	size	was	larger	in	group	A	ie.	7.4	mm	than	group	B	ie.	6.5	mm	after	30	minutes.	The	observed	difference	was	statistically	significant	(p<0.05).	All	pupils	reached	their	maximum	diameter	at	 45	minutes	 in	Group	A	 the	mean	pupil	 diameter	was	8.2	mm	and	for	group	B	was	7.48	mm.	The	ob-served	 difference	 was	 statistically	 significant	(p<0.05).	The	 mean	 pupil	 size	 with	 Tropicamide	 and	 Phe-nylephrine	was	 significantly	 larger	 in	 Group	A	 (6.2	
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mm)	than	Group	B	(5.28	mm)	after	15	minutes	(P=	0.49).	 The	 mean	 pupil	 size	 with	 Tropicamide	 and	Phenylephrine	was	significantly	larger	in	Group	A(7.4	mm)	 than	 Group	 B	 (6.56	 mm)	 after	 30	 minutes	(P=0.03).	The	mean	pupil	size	with	Tropicamide	and	Phenylephrine	was	significantly	larger	in	Group	A(8.2	mm)	 than	 Group	 B	 (7.48	 mm)	 after	 45	 minutes	(P=0.12)	
Table 6: Comparison of mean pupil size of group A 
and B before dilation 
Group Mean Of Normal Pupil Size (mm)  
Group A 3.52 
Group B 2.84 
 
Figure 5: Comparison of mean pupil size of group A 
and B before dilation 
Table 7: Comparison of pupillary diameter after 15 
minutes, 30 minutes and 45 minutes of drug admin-
istration 
G
ro
up
 Mean of 
Normal  
Pupil 
Size(mm) 
Pupil 
Size  
After 15 
Minutes 
Pupil 
Size Af-
ter 30 
Minutes 
Pupil 
Size  
After 45 
Minutes 
A 3.52 6.2 mm 7.4 mm 8.2 mm 
B 2.84 5.28 mm 6.56 mm 7.48 mm 
 
Figure 6: Comparison of pupillary diameter after 15 
minutes, 30 minutes and 45 minutes of drug admin-
istration 
Rate	of	increase	in	Pupil	size	after	dilation	(table	
10)	In	group	A,	the	normal	pupil	size	was	3.52.	It	was	in-creased	2.68mm	after	15	minutes	and	then	the	pupil	size	became	6.2mm.	In	group	B,	the	normal	pupil	size	was	2.84.	It	was	increased	2.44	mm	after	15	minutes	and	reached	5.28	mm.	After	30	minutes	the	pupil	size	
was	increased	3.88	mm	and	reached	7.4	mm	in	group	A.	In	group	B	the	pupil	size	was	increased	by	3.72	mm	and	reached	6.56	mm.	After	45	minutes	the	pupil	size	of	group	A	was	increased	4.68	mm	to	reach	the	pupil	size	8.2	mm.	in	group	B	pupil	size	increased	by	4.64	mm	to	reach	7.48	mm.	As	per	the	study	it	was	found	that	there	is	a	gradual	increase	in	pupil	size	according	to	time	after	the	administration	of	one	drop	of	Tropi-camide	0.8	5	and	phenylephrine	5%.		
 
Figure 7: Comparison of pupil size of group A and B	
Table 8: Comparison of rate of increase in pupil size 
after dilation 
G
ro
up
 Mean of 
normal 
pupil size 
(mm) 
After 
15 min 
(mm) 
After 
30 min 
(mm) 
After 
45 min 
(mm) 
A 3.52 2.68  3.88 4.68 
B 2.84 2.44  3.72 4.64 
Dif-
fer-
ence 
0.68 0.18 0.16 0.04 
 
Figure 8: Comparison of rate of increase in pupil size 
after dilation	The	comparison	between	these	values	of	pupil	size	in	teenagers	and	geriatric	people	shows	that	there	was	only	a	small	difference	in	the	size	of	the	pupil	after	di-lation.	But	the	drug	produces	satisfactory	dilation	af-ter	 45	minutes	 in	 geriatric	 people,	which	 is	 less	 as	compared	to	teenagers.		The	current	study	showed	that	the	difference	of	the	pupil	size	between	teenagers	and	geriatric	people	af-ter	dilation	was	statistically	significant.	The	decrease	in	pupil	size	of	geriatric	subjects	in	group	B	may	be	
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due	to	the	factors	which	influence	the	structure	and	function	of	eye	of	the	old	age.	It	may	be	the	reduced	normal	pupil	size	of	aged	persons.	The	size	of	the	pu-pil	 varies	 with	 age.	 They	 become	 smaller	 with	 in-creasing	age.	As	we	age	the	muscles	that	control	our	pupil	size	and	reaction	to	 lights	 lose	some	strength.	This	causes	pupil	to	become	smaller	and	less	respon-sible	to	changes	in	ambient	lighting.	There	is	another	important	factor	which	is	responsible	for	tis	findings	may	 be	 decreased	 drug	 permeability	 across	 cornea	and	the	functional	loss	of	corneal	endothelium	due	to	old	age.	Even	though	all	these	factors	may	influence	the	geriatric	 subjects’	 eye,	 the	drug	produced	satis-factory	dilation	in	them.	But	as	compared	to	teenag-ers	it	was	less.	The	difference	between	pupil	size	in	both	groups	was	statistically	significant	(p<0.05)	.	All	the	subjects	in	group	B	achieved	pupil	size	larger	than	6	mm.	This	is	an	acceptable	size	for	conducting	gen-eral	fundus	examination	therefore	the	study	showed	that	the	drug	produced	satisfactory	pupillary	dilation	in	geriatric	subjects	also.		
LIMITATIONS	The	study	population	was	small.	If	the	study	was	con-ducted	with	larger	group	of	subjects	for	a	long	dura-tion	 more	 significant	 results	 would	 have	 been	 ob-tained.	The	 current	 study	 followed	 the	 pupil	 size	 for	 45	minutes	after	eye	drops	administration.	Thus,	the	ef-fects	beyond	45	minutes	could	not	be	analaysed.		
CONCLUSION	The	current	study	concludes	that	the	mydriatic	effect	produced	 by	 the	 combination	 of	 0.8%	Tropicamide	and	5%	Phenylephrine	in	teenagers	was	higher	than	geriatric	people.	There	was	a	significant	 increase	 in	pupil	 size	 after	 administering	 the	 drug,	 which	 was	higher	 in	 teenagers.	 The	 observed	 difference	 was	found	 to	 be	 statistically	 significant.	 The	 decreased	mydriatic	effect	in	geriatric	people	may	be	due	to	the	structural	and	functional	changes	of	eye	in	old	age.	
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